The ARWR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARWR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARWR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ARWR Detailed Price Forecast - CNN Money | View ARWR Detailed Summary - Google Finance | ||
View ARWR Detailed Summary - Yahoo! Finance | View ARWR Stock Research & Analysis - Zacks.com |
View ARWR Trends & Analysis - Trade-Ideas | View ARWR Major Holders - Barrons | ||
View ARWR Call Transcripts - NASDAQ | View ARWR Breaking News & Analysis - Seeking Alpha | ||
View ARWR Annual Report - CompanySpotlight.com | View ARWR OTC Short Report - OTCShortReport.com | ||
View ARWR Fundamentals - TradeKing | View ARWR SEC Filings - Bar Chart | ||
View Historical Prices for ARWR - The WSJ | View Performance/Total Return for ARWR - Morningstar | ||
View the Analyst Estimates for ARWR - MarketWatch | View the Earnings History for ARWR - CNBC | ||
View the ARWR Earnings - StockMarketWatch | View ARWR Buy or Sell Recommendations - MacroAxis | ||
View the ARWR Bullish Patterns - American Bulls | View ARWR Short Pain Metrics - ShortPainBot.com |
View ARWR Stock Mentions - StockTwits | View ARWR Stock Mentions - PennyStockTweets | ||
View ARWR Stock Mentions - Twitter | View ARWR Investment Forum News - Investor Hub | ||
View ARWR Stock Mentions - Yahoo! Message Board | View ARWR Stock Mentions - Seeking Alpha |
View Insider Transactions for ARWR - SECform4.com | View Insider Transactions for ARWR - Insider Cow | ||
View ARWR Major Holdings Summary - CNBC | View Insider Disclosure for ARWR - OTC Markets | ||
View Insider Transactions for ARWR - Yahoo! Finance | View Institutional Holdings for ARWR - NASDAQ |
View ARWR Stock Insight & Charts - FinViz.com | View ARWR Investment Charts - StockCharts.com | ||
View ARWR Stock Overview & Charts - BarChart | View ARWR User Generated Charts - Trading View |
Turnstone Biologics Appoints William Waddill to its Board of Directors
Posted on Tuesday April 16, 2024
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced the appointment of industry veteran William Waddill to the Company’s Board of Directors. The Company also announced that Patrick Machado has stepped down as a member o
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses
Posted on Tuesday April 16, 2024
Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
Posted on Sunday April 07, 2024
PASADENA, Calif., April 07, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented final data from the double-blind treatment period of its Phase 2 SHASTA-2 study of investigational plozasiran (formerly ARO-APOC3) in patients with severe hypertriglyceridemia (SHTG). Results from the SHASTA-2 study showed dramatic, consistent, and sustained reductions in Apolipoprotein C-III (APOC3) and triglycerides and improvement in multiple atherogenic lipoprotein levels. These data were present
Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...
Posted on Wednesday April 03, 2024
James Hamilton, Chief Discovery and Translational Medicine Officer at Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 6,000 shares of the company on April 1, 2024, according to a recent SEC filing.